Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
Demand Outlook for GLP-1 Nutritional Support Market in the United States The CAGR of the GLP-1 nutritional support market in the United States rose from approximately 8.2% during 2020 to 2024 to 11.2% for 2025 to 2035, supported by stronger insurance reimbursement frameworks and physician adoption across outpatient metabolic care
Glucagon-like peptide-1 receptor agonists and dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonists in the treatment of obesity/metabolic syndrome, prediabetes/diabetes and non-alcoholic fatty liver disease-current evidence
S., Meier, J
A study conducted on a mouse model of colitis found that the GLP-1RA liraglutide significantly improves IBD activity
US$ 21.29
US$ 21.41
US$ 20.38
US$ 21.62
